Literature DB >> 7981154

Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood.

N Ishii1, T Takeshita, Y Kimura, K Tada, M Kondo, M Nakamura, K Sugamura.   

Abstract

We have established two rat mAbs, TUGh4 and TUGh5, specific for the human gamma chain of the IL-2 receptor (IL-2R), which is known to be shared among receptors for IL-2, IL-4 and IL-7. The antibodies bound to cell lines transfected with the human gamma chain gene but not to their parental cell lines, and precipitated 65-70 and 80-90 kDa cell surface molecules from lysates of human T cells surface-labeled with Na125I and chemically cross-linked with [125I]IL-2 respectively. Flow cytometry with TUGh4 and TUGh5 detected the gamma chain in a wide variety of peripheral blood cell populations including CD4+ T cells, CD8+ T cells, CD20+ B cells, CD56+ natural killer cells, CD14+ monocytes and granulocytes, contrasting with expression of the alpha and beta chains of IL-2R.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981154     DOI: 10.1093/intimm/6.8.1273

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  15 in total

1.  Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis.

Authors:  D Girard; R Paquin; A D Beaulieu
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  A novel mutant gammac chain from a patient with typical phenotype of X-linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL-2 and IL-4 receptor action.

Authors:  S Kumaki; H D Ochs; K K Kuropatwinski; T Konno; M S Timour; D Cosman; H Baumann
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

3.  Complete arrest from pro- to pre-B cells in a case of B cell-negative severe combined immunodeficiency (SCID) without recombinase activating gene (RAG) mutations.

Authors:  K Agematsu; H Nagumo; S Hokibara; T Mori; T Wada; A Yachie; H Kanegane; T Miyawaki; K Sugita; H Karasuyama; A Komiyama
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

4.  Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro.

Authors:  J Li; S Gyorffy; S Lee; C S Kwok
Journal:  Inflammation       Date:  1996-08       Impact factor: 4.092

5.  Expression of IL-2R, IL-4R, IL-6R on peripheral blood lymphocytes in systemic lupus erythematosus and correlation with disease activity: a prospective study.

Authors:  E Y Chan; C S Lau; H Zola
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

Review 6.  X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis.

Authors:  N L Farner; S D Voss; P M Sondel
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

7.  Hrs recognizes a hydrophobic amino acid cluster in cytokine receptors during ubiquitin-independent endosomal sorting.

Authors:  Yuji Amano; Yuki Yamashita; Katsuhiko Kojima; Kazuhisa Yoshino; Nobuyuki Tanaka; Kazuo Sugamura; Toshikazu Takeshita
Journal:  J Biol Chem       Date:  2011-03-01       Impact factor: 5.157

8.  Expression of common gamma chain on peripheral blood mononuclear cells in Crohn's disease.

Authors:  I Kirman; O H Nielsen
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

9.  Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).

Authors:  M Nielsen; A Svejgaard; C Röpke; M Nordahl; N Odum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Interleukin 2 modulates ion secretion and cell proliferation in cultured human small intestinal enterocytes.

Authors:  E V O'Loughlin; G P Pang; R Noltorp; C Koina; R Batey; R Clancy
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.